
From Oreo's real-time swagger to Kenvue's digital shelf, Jonathan Halvorson has built a career around one deceptively hard brief: make global marketing more personal without making it creepy, generic or needlessly complicated.
It stopped making the Band-Aid. What is left is a $94-billion bet that the future of Johnson & Johnson is written on a prescription pad and a robotic arm.